A new drug has shown promise for Dementia with Lewy Bodies in the just released data from the SHIMMER (CT1812) trial. The data just released revealed that participants taking CT1812 performed better across measures of behavior, function, cognition, and movement. The treatment was… pic.twitter.com/Tr1ajZQGTO
Teacher, Clinical Supervisor
Clinical Associate Professor, Psychiatry
University of Florida
Affiliation is for identification only. All content and opinions are my own.
View more posts
Gator Psychiatry 